Full Text View
Tabular View
No Study Results Posted
Related Studies
Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections
This study is currently recruiting participants.
Verified May 2013 by AstraZeneca
Study NCT01499290   Information provided by AstraZeneca

First Received on December 19, 2011.   Last Updated on May 7, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
CAZ-AVI
Metronidazole
Meropenem
Additional drug interventions recognized in this trial
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Ceftazidime
More general drug interventions related to this trial
Anti-Bacterial Agents
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca
Cerexa, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services